KARLA ACEVEDO: Open Payments
NPI 1306576533 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 16 payments from 8 companies in 2025. Trend: 2023 $901 · 2024 $65 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $137 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| ABBVIE INC. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, Sunosi, MOUNJARO, Kerendia, JARDIANCE, NUCALA, OFEV, LINZESS.
Industry payments across TX — which companies pay providers there.
